文献速递系统性红斑狼疮

狼疮患者的药物可及性与费用相关不依从:MILES队列研究

Access and Cost-Related Nonadherence to Prescription Medications Among Lupus Patients and Controls: The Michigan Lupus Epidemiology and Surveillance Program.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2021-09-24

该研究基于密歇根狼疮流行病学与监测(MILES)队列,于2014-2015年通过结构化访谈收集654名参与者(462例SLE患者、192例对照)的社会人口学和处方数据。结果显示SLE患者与对照在无法获取处方药的比例上相似(12.1% vs 9.4%,P不显著),但SLE患者因节省费用而报告费用相关不依从的比例是对照的两倍(21.7% vs 10.4%,P=0.001),且更倾向于向医生询问低价替代方案(23.8% vs 15.6%,P=0.02)。调整收入、种族和保险状态等多变量后主要发现仍持续存在。

要点

  • SLE患者费用相关不依从(21.7%)显著高于对照(10.4%),P=0.001。
  • 不足1/4的SLE患者会向医生询问低价药物替代方案。
  • 药物可及性障碍在SLE与对照间无显著差异(12.1% vs 9.4%)。

核心结论

  • SLE患者比一般人群对照更常报告费用相关处方不依从,包括跳过剂量、减少用药和延迟取药。
  • 尽管费用相关不依从常见,但不足1/4的患者会向医生询问低价药物。
  • 考虑药物费用在患者决策中的作用可为改善药物可及性和依从性提供途径。

研究设计与样本

  • 基于人群的队列研究,数据来自密歇根狼疮流行病学与监测(MILES)队列2014-2015年结构化访谈。
  • 共654名参与者完成基线访视,包括462例SLE患者和192例频率匹配对照。

主要发现

  • SLE患者与对照报告无法获取处方药的频率相似(12.1% vs 9.4%,P不显著)。
  • SLE患者因省钱而报告过去12个月费用相关处方不依从的比例为21.7%,对照为10.4%(P=0.001)。
  • SLE患者向医生询问低价替代方案的比例为23.8%,对照为15.6%(P=0.02)。
  • 收入、种族和保险状态存在差异,但调整这些变量及其他变量后主要发现持续存在。

临床怎么用

  • 风湿免疫科医生应主动询问SLE患者的药物费用负担及费用相关不依从行为。
  • 可考虑主动提供低价替代方案以改善SLE患者的用药依从性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Medication access and adherence are important determinants of health outcomes. We investigated factors associated with access and cost-related nonadherence to prescriptions in a population-based cohort of systemic lupus erythematosus (SLE) patients and controls. METHODS: Detailed sociodemographic and prescription data were collected by structured interview in 2014-2015 from participants in the Michigan Lupus Epidemiology and Surveillance (MILES) cohort. We compared access between cases and frequency-matched controls and examined associated factors in separate multivariable logistic regression models. RESULTS: A total of 654 participants (462 SLE patients, 192 controls) completed the baseline visit; 584 (89%) were female, 285 (44%) were Black, and the mean age was 53 years. SLE patients and controls reported similar frequencies of being unable to access prescribed medications (12.1% versus 9.4%, respectively; P was not significant). SLE patients were twice as likely as controls to report cost-related prescription nonadherence in the preceding 12 months to save money (21.7% versus 10.4%; P = 0.001) but were also more likely to ask their doctor for lower cost alternatives (23.8% versus 15.6%; P = 0.02). Disparities were found in association with income, race, and health insurance status, but the main findings persisted after adjusting for these and other variables in multivariable models. CONCLUSION: SLE patients were more likely than controls from the general population to report cost-related prescription nonadherence, including skipping doses, taking less medicine, and delaying filling prescriptions; yet, <1 in 4 patients asked providers for lower cost medications. Consideration of medication costs in patient decision-making could provide a meaningful avenue for improving access and adherence to medications.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Minhas D, Marder W, Harlow S, et al. Access and Cost-Related Nonadherence to Prescription Medications Among Lupus Patients and Controls: The Michigan Lupus Epidemiology and Surveillance Program. Arthritis Care Res (Hoboken). 2021. PMID: 32741110. doi:10.1002/acr.24397

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。